Author

I V Ryzhko

Observed names: I. V. Ryzhko, V Ryzhko, И В Рыжко

Observed institution: Rostov-on-Don Anti-plague Institute Rospotrebnadzor

OpenAlex ID: A5108585870

[Virulence of rifampicin and quinolone resistant mutants of strains of plague microbe with Fra+ and Fra- phenotypes].

1994 · I V Ryzhko, A I Shcherbaniuk, et al. · PubMed · 14

[Doxycycline in the prevention of experimental plague induced by plague microbe variants].

1992 · E D Samokhodkina, I V Ryzhko, et al. · PubMed · 6

[Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe].

1998 · I V Ryzhko, E D Samokhodkina, et al. · PubMed · 4

[Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain].

2004 · I V Ryzhko, R I Tsuraeva, et al. · PubMed · 3

[Formation of virulent antigen-modified mutants (Fra-, Fra-Tox-) of plague bacteria resistant to rifampicin and quinolones].

2003 · I V Ryzhko, A I Shcherbaniuk, et al. · PubMed · 3

[Experimental evaluation of prospects for the use of beta-lactams in plague infection caused by pathogens with plasmid resistance to penicillins].

1998 · I V Ryzhko, E D Samokhodkina, et al. · PubMed · 3

[A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].

1997 · I V Ryzhko, A I Shcherbaniuk, et al. · PubMed · 3

[Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].

1996 · I V Ryzhko, R I Tsuraeva, et al. · PubMed · 3

[Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].

1994 · E D Samokhodkina, I V Ryzhko, et al. · PubMed · 3

[Ceftriaxone in prevention and treatment of experimental plague infection].

1993 · I V Ryzhko, E D Samokhodkina, et al. · PubMed · 3

[Detection of persistent resistance to antibacterial drugs in various strains of Francisella tularensis].

1992 · N V Pavlovich, N K Tynkevich, et al. · PubMed · 3

[Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].

2010 · I V Ryzhko, A V Trishina, et al. · PubMed · 2

[Prophylactic use of ceftriaxone in combination with F I antigen immunization in studies on uninbred albino mice infected by Yersinia pestis. Antiplague immunity development].

2006 · I V Ryzhko, I A Moldavan, et al. · PubMed · 2

[Cefoperazone in the prevention and treatment of experimental plague caused by typical and fraction-free pathogen strains in white mice].

1994 · V V Pasiukov, I V Ryzhko, et al. · PubMed · 2

[Comparative characteristics of biological properties of Francisella tularensis strains isolated in the USSR].

1991 · N V Pavlovich, B N Mishan'kin, et al. · PubMed · 2

[Comparative study of the effectiveness of amikacin and streptomycin in experimental tularemia].

1990 · N K Tynkevich, N V Pavlovich, et al. · PubMed · 2

[In vitro induction of transmissive resistance to tetracycline, chloramphenicol and ampicillin chloramphenicol in Vibrio cholera non-O1/non-O139 serogroups isolated within 1990-2005].

2011 · N A Selianskaia, I V Ryzhko, et al. · PubMed · 1

[Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice].

2009 · I V Ryzhko, R I Tsuraeva, et al. · PubMed · 1

[Efficacy of cefixime and cefepime vs. other cephalosporins in experimental plague of albino mice due to variants FI+ and FI- of the plague microbe].

2007 · I V Ryzhko, A I Shcherbaniuk, et al. · PubMed · 1

[Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].

2006 · A I Shcherbaniuk, E Iu Liukshina, et al. · PubMed · 1

[Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].

2005 · Iu V Smorodinova, A I Shcherbaniuk, et al. · PubMed · 1

[Use of monoclonal antibodies to plague microbe antigens at the early stage of infection in white mice for enhancement of the late streptomycin and doxycycline treatment].

2003 · I V Ryzhko, R I Tsuraeva, et al. · PubMed · 1

[Characterization of Vibrio cholerae eltor in the city of Kazan in 2001].

2002 · G G Onishchenko, Iu M Lomov, et al. · PubMed · 1

[Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen].

2002 · E D Samokhodkina, A I Shcherbaniuk, et al. · PubMed · 1

[Experimental evaluation of efficacy of Lactobacilli in prophylaxis and treatment of cholera].

2001 · I D Bardykh, V D Krylikov, et al. · PubMed · 1

Works count: 53

Citation count: 70

H-index: 3

I10-index: 1